Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.

ABSTRACT:

SUBMITTER: Laurent C 

PROVIDER: S-EPMC10755216 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature